Degenerative neurological disorders

Fears over cancer risk with MS drug cladribine unfounded

Cladribine was refused a licence for multiple sclerosis because of fears it increases the risk of cancer, but a new analysis finds no evidence to support this.…

Delayed dizziness after standing is early sign of orthostatic hypotension

Patients who have a delayed drop in blood pressure are likely to see the condition progress, which is associated with the development of neurodegenerative conditions and a 50% mortality rate.…

Brains of CJD victims show signs of Alzheimer’s pathology

Victims of Creutzfeldt–Jakob disease show evidence of Alzheimer’s pathology, suggests new research. But neuroscientists have quashed fears that people can “catch” Alzheimer’s.…

Stopping antihypertensives does not slow cognitive decline in older patients

In patients over 75 years, low blood pressure can worsen cognitive decline, but researchers found that stopping antihypertensives did not help.…

Closing in on Alzheimer’s disease

Knowledge about the neuropathology of Alzheimer’s disease has blossomed over the past few decades, leading to a better understanding of the condition and new ways to attack it.…

Data suggest that new Alzheimer’s drug solanezumab has disease-modifying properties

A monoclonal antibody in development for the treatment of Alzheimer’s disease (AD) may have disease-modifying properties, according to new research.…

Glitazone drugs could play a role in prevention of Parkinson’s disease

Patients who take glitazone drugs to manage their diabetes may have some protection from developing Parkinson’s disease, suggests new research.…

Clinical Pharmacist’s monthly news round-up: the top 10 in the past month

What has been happening in the world of pharmacy? Here’s our pick of must-read news from the past month.…

Black patients with Alzheimer’s disease more likely to have mixed pathology

Alzheimer’s disease is not well-studied in black patients and researchers say that specific treatment strategies may be needed.…

Fish oil and antioxidants help clear Alzheimer’s proteins in brains of people without the disease

A study finds that supplements can help clear amyloid-β protein, which accumulates in the brain during Alzheimer’s disease, but only in patients with minor cognitive impairment or no disease.…